Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC
Clinical trial NCT04507217 · COMPLETED
Trial details
- NCT number
- NCT04507217
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2022-11-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.